Immunocytochemical study of estrogen receptor er and epidermal growth factor receptor egfr in primary tumors and involved nodes of human breast cancer
Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y.
Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 45
1990
ISSN/ISBN: 0171-5216 Accession: 031811541
PDF emailed within 1 workday: $29.90
Related References
Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y. 1991: Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer Cancer 68(3): 532-537Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y. 1989: The receptor status between in primary tumor and in its involved regional node referring to estrogen receptor and epidermal growth factor receptor in human breast cancer: preliminary report Nihon Geka Gakkai Zasshi 90(10): 1820
Tomiguchi, M.; Yamamoto, Y.; Yamamoto-Ibusuki, M.; Goto-Yamaguchi, L.; Fujiki, Y.; Fujiwara, S.; Sueta, A.; Hayashi, M.; Takeshita, T.; Inao, T.; Iwase, H. 2016: Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer Cancer Science 107(4): 491-498
Toi, M.; Hamada, Y.; Nakamura, T.; Mukaida, H.; Suehiro, S.; Wada, T.; Toge, T.; Niimoto, M.; Hattori, T. 1989: Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion International Journal of Cancer 43(2): 220-225
Toi, M. 1988: Comparative study on estrogen receptor, epidermal growth factor and epidermal growth factor receptor using immunocytochemical and biochemical assays in breast cancer Nihon Geka Gakkai Zasshi 89(5): 725-736
Zabransky, D.J.; Park, B.H. 2014: Estrogen receptor and receptor tyrosine kinase signaling: use of combinatorial hormone and epidermal growth factor receptor/human epidermal growth factor receptor 2-targeted therapies for breast cancer Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32(10): 1084-1086
Zabransky, D.J.; Ben Ho, P.A.R.K. 2014: Estrogen Receptor and Receptor Tyrosine Kinase Signaling: Use of Combinatorial Hormone and Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2―Targeted Therapies for Breast Cancer Journal of Clinical Oncology 32(10): 1084-1086
LeJeune, S.; Leek, R.; Horak, E.; Plowman, G.; Greenall, M.; Harris, A.L. 1993: Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer Cancer Research 53(15): 3597-3602
Umemura, S.; Takekoshi, S.; Suzuki, Y.; Saitoh, Y.; Tokuda, Y.; Osamura, R.Yoshiyuki. 2005: Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression Oncology Reports 14(2): 337-343
Wang, Y.; Ikeda, D.M.; Narasimhan, B.; Longacre, T.A.; Bleicher, R.J.; Pal, S.; Jackman, R.J.; Jeffrey, S.S. 2008: Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression Radiology 246(2): 367-375
Dihge, L.; Bendahl, P.är.-O.; Grabau, D.; Isola, J.; Lövgren, K.; Rydén, L.; Fernö, M.år. 2008: Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer Breast Cancer Research and Treatment 109(2): 255-262
Tsutsui, S.; Ohno, S.; Murakami, S.; Hachitanda, Y.; Oda, S. 2002: Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer Breast Cancer Research and Treatment 71(1): 67-75
Polychronis, A.; Sinnett, H.D.; Hadjiminas, D.; Singhal, H.; Mansi, J.L.; Ali, S.; Slade, M.J.; Shousha, S.; Morrisson, K.; Coombes, R.C. 2016: Anti-proliferative and molecular effects of neoadjuvant (pre-operative) gefitinib alone or in combination with anastrozole in epidermal growth factor receptor (EGFR) positive, estrogen receptor alpha (ERα) positive patients with primary breast cancer Journal of Clinical Oncology 23(16_Suppl): 552-552
Fujii, K.; Watanabe, R.; Ando, T.; Kousaka, J.; Mouri, Y.; Yoshida, M.; Imai, T.; Nakano, S.; Fukutomi, T. 2017: Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions Biomedical Reports 7(6): 535-542
Garcìa Castro, C.; Ravina, M.; Castro, V.; Salido, E.C. 1993: Expression of epidermal growth factor receptor (proto-oncogene c-erbB-1) and estrogen receptor in human breast carcinoma. An immunocytochemical study of 70 cases Archives of Gynecology and Obstetrics 252(4): 169-177